KELOWNA, BRITISH COLUMBIA – January 14, 2020 – Citation Growth Corp. (CSE: CGRO) (OTCQX: CGOTF) (“Citation” or the “Company”), a licensed cannabis cultivator and producer, announces today that Howard Misle has resigned as Chief Executive Officer and a Board Member effective January 13, 2020. The Board of Directors has already begun interviewing prospective CEO candidates and expects to make an announcement shortly. In the interim, Mr. Rahim Mohamed will be the interim CEO.

The Company is also pleased to announce that it has appointed Mr. Kevin Cornish as its Chief Financial Officer effectively immediately.

Mr. Cornish has roots all over Eastern Canada, spending most of his life in Halifax Nova Scotia where he completed his education at Saint Mary’s University. He has worked in the service, hospitality, construction and cannabis industries over the course of his career. His expertise is focused in leadership, performance management, company growth and finance. He has experience sitting on the boards of both not for profit and for profit companies, volunteered with child development groups and is an advocate for mental health. Mr. Cornish has helped start up and mature companies grow in current and new markets. In 2018 he joined the cannabis industry due to having seen many people he knows positively affected by THC and CBD. Taking part in Canada’s history, Mr. Cornish was part of a Cannabis company that brought recreational Cannabis to Alberta and Canada. Mr. Cornish enjoys the many challenges that come with working in this industry leading up to legalization, post legalization and cannabis 2.0. With over 15 years of leadership experience in operations and finance, Mr. Cornish continues to grow along with this industry both personally and professionally.

Due to this change in management, the company has deemed it necessary to postpone its AGM scheduled for January 24, 2020 in Las Vegas Nevada to allow for an updated Management Information Circular to be filed and circulated to shareholders. Once a new date and location has been scheduled, management will issue out a News Release.

“We, the management and board, apologize for any inconvenience this may have caused any shareholders who may have already booked flights and hotels. We will be diligent and begin placing a new CEO as soon as possible” quoted Rahim Mohamed, President and Interim CEO.

About Citation Growth Corp.

Citation Growth Corp. is a publicly traded company that has been investing in the medical and recreational cannabis space since 2014. Citation has rapidly expanded its operating portfolio to include cultivation, production, and dispensary locations in key North American state-legal jurisdictions and is seeking expansion opportunities worldwide.

For Further Information:

Rahim Mohamed, President
1-877-438-5448 Extension 718
RM@citationgrowth.com

Paul Searle, Corporate Communications
1-877-438-5448 Extension 714
psearle@citationgrowth.com

http://citationgrowth.com

Stock Exchanges:

Citation trades in Canada, under the ticker symbol “CGRO” on the CSE, and in the U.S., under the ticker symbol “CGOTF” on the OTCQX Best Market (the “OTCQX”). The Company also trades on other recognized platforms in Europe including Frankfurt, Stuttgart, Tradegate, L & S, Quotnx, Dusseldorf, Munich, and Berlin.

Neither the CSE nor its Regulation Services Provider, nor the OTCQX has approved nor disapproved the contents of this press release. Neither the CSE, nor the OTCQX accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements:

This news release contains forward-looking statements that relate to our current expectations and views of future events. These statements relate to future events or future performance. Statements which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, outlook, expectations or intentions regarding the future including words or phrases such as “anticipate”, “become”, “objective”, “may”, “will”, “might”, “should”, “could”, “can”, “intend”, “expect”, “believe”, “estimate”, “predict”, “potential”, “plan”, “is designed to”, “project”, “continue”, or similar expressions suggest future outcomes or the negative thereof or similar variations. Forward-looking statements may also include, among other things, statements about the Company’s: future business strategy; operations and growth strategies; expectations of obtaining licenses and permits; expectations regarding expenses, sales and operations; future customer concentration; anticipated cash needs and estimates regarding capital requirements and the need for additional financing; ability to raise future financing; completion of all proposed site phases; the ability to expand into other states; expectations of operational efficiencies; total processing capacity; the ability to anticipate the future needs of customers; plans for future products and enhancements of existing products; future growth strategy and growth rate; future intellectual property; regulatory approvals and other matters; and anticipated trends and challenges in the markets in which the Company may operate.

Such forward-looking statements are subject to known and unknown risks, uncertainties and other important factors that may cause the actual results to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: business, economic and capital market conditions; the ability to manage the Company’s operating expenses, which may adversely affect the Company’s financial condition; the Company’s ability to remain competitive; regulatory uncertainties;

market conditions and the demand and pricing for our products; exchange rate fluctuations; security threats; the Company’s relationships with its customers, distributors and business partners; the Company’s ability to attract, retain and motivate qualified personnel; industry competition; the impact of technology changes on the Company’s products and industry; the Company’s ability to successfully maintain and enforce its intellectual property rights and defend third-party claims of infringement of their intellectual property rights; the impact of litigation that could materially and adversely affect our business; the Company’s ability to manage its working capital; and the Company’s dependence on key personnel. The Company is not a positive cash flow company and it may not actually achieve its plans, projections, or expectations (the Company has a history of losses).

Except as required by law, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither the Company nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this news release.

KELOWNA, BRITISH COLUMBIA – January 7th, 2020 – Citation Growth Corp. (CSE: CGRO) (OTCQX: CGOTF) (“Citation” or the “Company”), a licensed cannabis cultivator and producer, is pleased to provide a corporate update.

US Focus in High Gear through Further Asset Rationalization

On December 23rd, 2019, Citation entered into an agreement to dispose of its Magna Bay asset for gross proceeds of $825,000. This asset disposition continues the strategy of Citation to further focus on its Nevada asset base where it is seeing stronger capital efficiency and return on invested capital.

The sale of the assets will bring in $600,000.00 in cash at closing and an additional $225,000.00 to be paid later in 2020.

After the closing on December 23rd, 2019, the proceeds from the transaction were deployed into Citation’s 100% owned and operation Pahrump, Nevada cultivation facility and the 100% owned and operated North Las Vegas “APEX” extraction facility located in North Las Vegas. Citation intends to continue to invest in its Nevada asset base and in 2020 will continue with its proposed expansion of its Pahrump facility. As previously announced, upon full build out, the Company’s Pahrump operations will have total output of 16,800 lbs / year across 50,000 sq ft of grow.

About Citation Growth Corp.

Citation Growth Corp. is a publicly traded company that has been investing in the medical and recreational cannabis space since 2014. Citation has rapidly expanded its operating portfolio to include cultivation, production, and dispensary locations in key North American state-legal jurisdictions and is seeking expansion opportunities worldwide.

For Further Information:

Rahim Mohamed, President
1-877-438-5448 Extension 718
RM@citationgrowth.com

Paul Searle, Corporate Communications
1-877-438-5448 Extension 714
psearle@citationgrowth.com

http://citationgrowth.com

Stock Exchanges:

Citation trades in Canada, under the ticker symbol “CGRO” on the CSE, and in the U.S., under the ticker symbol “CGOTF” on the OTCQX Best Market (the “OTCQX”). The Company also trades on other recognized platforms in Europe including Frankfurt, Stuttgart, Tradegate, L & S, Quotnx, Dusseldorf, Munich, and Berlin.

Neither the CSE nor its Regulation Services Provider, nor the OTCQX has approved nor disapproved the contents of this press release. Neither the CSE, nor the OTCQX accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements:

This news release contains forward-looking statements that relate to our current expectations and views of future events. These statements relate to future events or future performance. Statements which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, outlook, expectations or intentions regarding the future including words or phrases such as “anticipate”, “become”, “objective”, “may”, “will”, “might”, “should”, “could”, “can”, “intend”, “expect”, “believe”, “estimate”, “predict”, “potential”, “plan”, “is designed to”, “project”, “continue”, or similar expressions suggest future outcomes or the negative thereof or similar variations. Forward-looking statements may also include, among other things, statements about the Company’s: future business strategy; operations and growth strategies; expectations of obtaining licenses and permits; expectations regarding expenses, sales and operations; future customer concentration; anticipated cash needs and estimates regarding capital requirements and the need for additional financing; ability to raise future financing; completion of all proposed site phases; the ability to expand into other states; expectations of operational efficiencies; total processing capacity; the ability to anticipate the future needs of customers; plans for future products and enhancements of existing products; future growth strategy and growth rate; future intellectual property; regulatory approvals and other matters; and anticipated trends and challenges in the markets in which the Company may operate.

Such forward-looking statements are subject to known and unknown risks, uncertainties and other important factors that may cause the actual results to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: business, economic and capital market conditions; the ability to manage the Company’s operating expenses, which may adversely affect the Company’s financial condition; the Company’s ability to remain competitive; regulatory uncertainties;

market conditions and the demand and pricing for our products; exchange rate fluctuations; security threats; the Company’s relationships with its customers, distributors and business partners; the Company’s ability to attract, retain and motivate qualified personnel; industry competition; the impact of technology changes on the Company’s products and industry; the Company’s ability to successfully maintain and enforce its intellectual property rights and defend third-party claims of infringement of their intellectual property rights; the impact of litigation that could materially and adversely affect our business; the Company’s ability to manage its working capital; and the Company’s dependence on key personnel. The Company is not a positive cash flow company and it may not actually achieve its plans, projections, or expectations (the Company has a history of losses).

Except as required by law, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither the Company nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this news release.

Kelowna, British Columbia and Las Vegas, Nevada– December 17th, 2019 – Citation Growth Corp. (CSE: CGRO) (OTCQX: CGOTF) (“Citation” or the “Company”), a licensed cannabis cultivator and producer, is pleased to announce that its Fiore Cannabis – Super Glue strain has won 1 st Place at the High Times Cannabis Cup in Nevada for 2019 in the Hybrid Flower Category. This is the first Cannabis Cup win for Citation. This strain was developed in house by the genetics team at Citation at the APEX Campus in North Las Vegas and represents our Triple-Certified Organic family of flower. These further cements the organizational efficiencies and success that have come since the merger with the ACC Group of Companies.

Howard Misle, CEO of Citation commented “I am extremely proud and honoured to see our in house developed strain get a High Times Cannabis Cup in its first year of sales. This strain has seen immense success since going on shelves in 2019. As we continue to ramp up our Apex and Pahrump facilities, I expect to see continued top-tier strains emerge from our in-house genetics team”

About Citation Growth Corp.

Citation Growth Corp. is a publicly traded company that has been investing in the medical and recreational cannabis space since 2014. Citation has rapidly expanded its operating portfolio to include cultivation, production, and dispensary locations in key North American state-legal jurisdictions and is seeking expansion opportunities worldwide.

For Further Information:

Rahim Mohamed, President
1-877-438-5448 Extension 718
RM@citationgrowth.com

Paul Searle, Corporate Communications
1-877-438-5448 Extension 714
psearle@citationgrowth.com

http://citationgrowth.com

Stock Exchanges:

Citation trades in Canada, under the ticker symbol “CGRO” on the CSE, and in the U.S., under the ticker symbol “CGOTF” on the OTCQX Best Market (the “OTCQX”). The Company also trades on other recognized platforms in Europe including Frankfurt, Stuttgart, Tradegate, L & S, Quotnx, Dusseldorf, Munich, and Berlin.

Neither the CSE nor its Regulation Services Provider, nor the OTCQX has approved nor disapproved the contents of this press release. Neither the CSE, nor the OTCQX accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements:

This news release contains forward-looking statements that relate to our current expectations and views of future events. These statements relate to future events or future performance. Statements which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, outlook, expectations or intentions regarding the future including words or phrases such as “anticipate”, “become”, “objective”, “may”, “will”, “might”, “should”, “could”, “can”, “intend”, “expect”, “believe”, “estimate”, “predict”, “potential”, “plan”, “is designed to”, “project”, “continue”, or similar expressions suggest future outcomes or the negative thereof or similar variations. Forward-looking statements may also include, among other things, statements about the Company’s: future business strategy; operations and growth strategies; expectations of obtaining licenses and permits; expectations regarding expenses, sales and operations; future customer concentration; anticipated cash needs and estimates regarding capital requirements and the need for additional financing; ability to raise future financing; completion of all proposed site phases; the ability to expand into other states; expectations of operational efficiencies; total processing capacity; the ability to anticipate the future needs of customers; plans for future products and enhancements of existing products; future growth strategy and growth rate; future intellectual property; regulatory approvals and other matters; and anticipated trends and challenges in the markets in which the Company may operate.

Such forward-looking statements are subject to known and unknown risks, uncertainties and other important factors that may cause the actual results to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: business, economic and capital market conditions; the ability to manage the Company’s operating expenses, which may adversely affect the Company’s financial condition; the Company’s ability to remain competitive; regulatory uncertainties;

market conditions and the demand and pricing for our products; exchange rate fluctuations; security threats; the Company’s relationships with its customers, distributors and business partners; the Company’s ability to attract, retain and motivate qualified personnel; industry competition; the impact of technology changes on the Company’s products and industry; the Company’s ability to successfully maintain and enforce its intellectual property rights and defend third-party claims of infringement of their intellectual property rights; the impact of litigation that could materially and adversely affect our business; the Company’s ability to manage its working capital; and the Company’s dependence on key personnel. The Company is not a positive cash flow company and it may not actually achieve its plans, projections, or expectations (the Company has a history of losses).

Except as required by law, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither the Company nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this news release.

KELOWNA, BRITISH COLUMBIA – December 5, 2019 – Citation Growth Corp. (CSE: CGRO) (OTCQX: CGOTF) (“Citation” or the “Company”), a licensed cannabis cultivator and producer, is pleased to provide a corporate update.

Branded Product Production Ramp Up

Over the four weeks, Citation has fundamentally changed its revenue generation model through the startup of its production license. Over the last two months, the Company has begun to shift from a pure-play cultivation company to that of company focused on the high growth branded concentrates market through the introduction of its branded lines of waxes, shatters, infused pre-rolls and triple certified organic vapes.

Since this branded production ramp up, Citation has produced approximately USD$1.0 million worth of wholesale branded products. The Company is awaiting final state approval before sales of these products will commence. The company is expecting this approval at the beginning of next week.

Citation expects to further increase its sales and margins through the roll out of its Diamante and Superior branded concentrate lines that will complement the existing Fiore, Garden of Weeden and Blunt Box brands.

California Dispensary Optimization and Margin Growth

In Desert Hot Springs California, the Company’s 100% owned and operated retail dispensary, Green Leaf Wellness continues to see increased revenue and profit margins since its strategic assets rationalization program began in September.

In October, the dispensary had revenues of approximately USD$130,000 with a gross profit margin of 55%, compared to revenues of approximately USD$100,000 per month with profit margins of approximately 26% prior to the amalgamation of Citation and ACC Group of Companies.

As previously stated, through operational optimization and execution which should be finished by the end of 2019, the Company is expecting annualized revenue of greater than USD$2mm per year with gross profit margins of greater than 65%.

About Citation Growth Corp.

Citation Growth Corp. is a publicly traded company that has been investing in the medical and recreational cannabis space since 2014. Citation has rapidly expanded its operating portfolio to include cultivation, production, and dispensary locations in key North American state-legal jurisdictions and is seeking expansion opportunities worldwide.

For Further Information:

Rahim Mohamed, President
1-877-438-5448 Extension 718
RM@citationgrowth.com

Paul Searle, Corporate Communications
1-877-438-5448 Extension 714
psearle@citationgrowth.com

www.citationgrowth.com

Stock Exchanges:

Citation trades in Canada, under the ticker symbol “CGRO” on the CSE, and in the U.S., under the ticker symbol “CGOTF” on the OTCQX Best Market (the “OTCQX”). The Company also trades on other recognized platforms in Europe including Frankfurt, Stuttgart, Tradegate, L & S, Quotnx, Dusseldorf, Munich, and Berlin.

Neither the CSE nor its Regulation Services Provider, nor the OTCQX has approved nor disapproved the contents of this press release. Neither the CSE, nor the OTCQX accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements:

This news release contains forward-looking statements that relate to our current expectations and views of future events. These statements relate to future events or future performance. Statements which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, outlook, expectations or intentions regarding the future including words or phrases such as “anticipate”, “become”, “objective”, “may”, “will”, “might”, “should”, “could”, “can”, “intend”, “expect”, “believe”, “estimate”, “predict”, “potential”, “plan”, “is designed to”, “project”, “continue”, or similar expressions suggest future outcomes or the negative thereof or similar variations. Forward-looking statements may also include, among other things, statements about the Company’s: future business strategy; operations and growth strategies; expectations of obtaining licenses and permits; expectations regarding expenses, sales and operations; future customer concentration; anticipated cash needs and estimates regarding capital requirements and the need for additional financing; ability to raise future financing; completion of all proposed site phases; the ability to expand into other states; expectations of operational efficiencies; total processing capacity; the ability to anticipate the future needs of customers; plans for future products and enhancements of existing products; future growth strategy and growth rate; future intellectual property; regulatory approvals and other matters; and anticipated trends and challenges in the markets in which the Company may operate.

Such forward-looking statements are subject to known and unknown risks, uncertainties and other important factors that may cause the actual results to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: business, economic and capital market conditions; the ability to manage the Company’s operating expenses, which may adversely affect the Company’s financial condition; the Company’s ability to remain competitive; regulatory uncertainties;

market conditions and the demand and pricing for our products; exchange rate fluctuations; security threats; the Company’s relationships with its customers, distributors and business partners; the Company’s ability to attract, retain and motivate qualified personnel; industry competition; the impact of technology changes on the Company’s products and industry; the Company’s ability to successfully maintain and enforce its intellectual property rights and defend third-party claims of infringement of their intellectual property rights; the impact of litigation that could materially and adversely affect our business; the Company’s ability to manage its working capital; and the Company’s dependence on key personnel. The Company is not a positive cash flow company and it may not actually achieve its plans, projections, or expectations (the Company has a history of losses).

Except as required by law, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither the Company nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this news release.

Kelowna, British Columbia – November 29, 2019 – Citation Growth Corp. (CSE: CGRO) (OTCQX: CGOTF) (“Citation” or the “Company”), a licensed cannabis cultivator and producer, announces that Ms. Nilda Rivera, the Company’s Chief Financial Officer, has tendered her resignation effective November 30, 2019. Ms. Rivera, who joined the Company in April 2019, will work with the Company on an orderly transition. The Company has commenced its search for a new CFO.

Rahim Mohamed, President and Director, commented, “On behalf of the Board, I would like to sincerely thank Ms. Rivera for her contributions to the Company and wish her the best in her future endeavours.”

The Board has appointed Rahim Mohamed, President, as Interim Chief Financial Officer while Citation completes its search for a permanent CFO.

About Citation Growth Corp.

Citation Growth Corp. is a publicly traded company that has been investing in the medical and recreational cannabis space since 2014. Citation has rapidly expanded its operating portfolio to

include cultivation, production, and dispensary locations in key North American state-legal jurisdictions and is seeking expansion opportunities worldwide.

For Further Information:

Rahim Mohamed, President
1-877-438-5448 Extension 718
RM@citationgrowth.com

Paul Searle, Corporate Communications
1-877-438-5448 Extension 714
psearle@citationgrowth.com

www.citationgrowth.com

Stock Exchanges:

Citation trades in Canada, under the ticker symbol “CGRO” on the CSE, and in the U.S., under the ticker symbol “CGOTF” on the OTCQX Best Market (the “OTCQX”). The Company also trades on other recognized platforms in Europe including Frankfurt, Stuttgart, Tradegate, L & S, Quotnx, Dusseldorf, Munich, and Berlin.

Neither the CSE nor its Regulation Services Provider, nor the OTCQX has approved nor disapproved the contents of this press release. Neither the CSE, nor the OTCQX accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements:

This news release contains forward-looking statements that relate to our current expectations and views of future events. These statements relate to future events or future performance. Statements which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, outlook, expectations or intentions regarding the future including words or phrases such as “anticipate”, “become”, “objective”, “may”, “will”, “might”, “should”, “could”, “can”, “intend”, “expect”, “believe”, “estimate”, “predict”, “potential”, “plan”, “is designed to”, “project”, “continue”, or similar expressions suggest future outcomes or the negative thereof or similar variations. Forward-looking statements may also include, among other things, statements about the Company’s: future business strategy; operations and growth strategies; expectations of obtaining licenses and permits; expectations regarding expenses, sales and operations; future customer concentration; anticipated cash needs and estimates regarding capital requirements and the need for additional financing; ability to raise future financing; completion of all proposed site phases; the ability to expand into other states; expectations of operational efficiencies; total processing capacity; the ability to anticipate the future needs of customers; plans for future products and enhancements of existing products; future growth strategy and growth rate; future intellectual property; regulatory approvals and other matters; and anticipated trends and challenges in the markets in which the Company may operate.

Such forward-looking statements are subject to known and unknown risks, uncertainties and other important factors that may cause the actual results to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: business, economic and capital market conditions; the ability to manage the Company’s operating expenses, which may adversely affect the Company’s financial condition; the Company’s ability to remain competitive; regulatory uncertainties;

market conditions and the demand and pricing for our products; exchange rate fluctuations; security threats; the Company’s relationships with its customers, distributors and business partners; the Company’s ability to attract, retain and motivate qualified personnel; industry competition; the impact of technology changes on the Company’s products and industry; the Company’s ability to successfully maintain and enforce its intellectual property rights and defend third-party claims of infringement of their intellectual property rights; the impact of litigation that could materially and adversely affect our business; the Company’s ability to manage its working capital; and the Company’s dependence on key personnel. The Company is not a positive cash flow company and it may not actually achieve its plans, projections, or expectations (the Company has a history of losses).

Except as required by law, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither the Company nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this news release.

Kelowna, British Columbia–(Newsfile Corp. – November 19, 2019) – Citation Growth Corp. (CSE: CGRO) (OTCQX: CGOTF) (“Citation” or the “Company”), a licensed cannabis cultivator and producer, announces that the Company is now in production to have dispensary shelves stocked with the Company’s Proprietary organic products. Highly anticipated among dispensaries and enthusiasts, 25,000 live resin and distillate vape pens are set for distribution right ahead of the holiday rush.

“Our goal has been to retain the true essence of the plant and preserve that quality in a truly premium organic line, bringing to market a top-quality flavorful selection sure to compete well against the top contenders in its league.” stated, Rahim Mohamed, President. Products being prepared for launch are expected to hit shelves the last week of November.

These exclusive blends are sourced from exquisite sources like FIORE – TRIPLE CERTIFIED to produce specific products like Diamonds Live Resin, Sugar Wax and Live Resin Vape Pen formulations.

FIORE was born out of the necessity to bring exceptional cannabis genetics, growing standards and passion to commercial cannabis – keeping craft cannabis alive. Having passed through the ranks of the cannabis industry over the last 15 years, Management has taken the experience, the knowledge and the pride from growing exceptional cannabis and delivered it to the Nevada marketplace, enabling consumers with the opportunity to experience the simplicity, elegance and quality, in the finished product, that is decades in the making.

Diamante Labs was founded on the determination to formulate high quality extracts by using closed loop hydrocarbon processes. Based on research, management believes that up to 100% of products produced will be sold almost immediately upon delivery to dispensaries.

Vape Pen wholesale prices for Citations premium products are as follows:

Diamante Labs Live Resin Disposable Vape Pen, 0.30 grams per pen $22.00

Diamante Labs Live Resin cartridge, 0.50 grams $35.00 each

Superior Extracts distillate Disposable Vape Pen, 0.30 grams $13.00 per pen

Superior Extracts distillate cartridge, 0.50 grams $22.00 each

Superior Brand will be mostly Distillate to start and Diamante Labs Vape Pen will be mostly Live Resin to start. Citation will begin to diversify its product lines in the upcoming months to offer our customers a wide range of premium quality extracts. Our focus will be on our Triple-Certified Organic Diamante Labs products that are healthier for the end user.

About Citation Growth Corp.

Citation Growth Corp. is a publicly traded company that has been investing in the medical and recreational cannabis space since 2014. Citation has rapidly expanded its operating portfolio to

include cultivation, production, and dispensary locations in key North American state-legal jurisdictions and is seeking expansion opportunities worldwide.

For Further Information:

Rahim Mohamed, President
1-877-438-5448 Extension 718
RM@citationgrowth.com

Paul Searle, Corporate Communications
1-877-438-5448 Extension 714
psearle@citationgrowth.com

http://citationgrowth.com

Stock Exchanges:

Citation trades in Canada, under the ticker symbol “CGRO” on the CSE, and in the U.S., under the ticker symbol “CGOTF” on the OTCQX Best Market (the “OTCQX”). The Company also trades on other recognized platforms in Europe including Frankfurt, Stuttgart, Tradegate, L & S, Quotnx, Dusseldorf, Munich, and Berlin.

Neither the CSE nor its Regulation Services Provider, nor the OTCQX has approved nor disapproved the contents of this press release. Neither the CSE, nor the OTCQX accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements:

This news release contains forward-looking statements that relate to our current expectations and views of future events. These statements relate to future events or future performance. Statements which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, outlook, expectations or intentions regarding the future including words or phrases such as “anticipate”, “become”, “objective”, “may”, “will”, “might”, “should”, “could”, “can”, “intend”, “expect”, “believe”, “estimate”, “predict”, “potential”, “plan”, “is designed to”, “project”, “continue”, or similar expressions suggest future outcomes or the negative thereof or similar variations. Forward-looking statements may also include, among other things, statements about the Company’s: future business strategy; operations and growth strategies; expectations of obtaining licenses and permits; expectations regarding expenses, sales and operations; future customer concentration; anticipated cash needs and estimates regarding capital requirements and the need for additional financing; ability to raise future financing; completion of all proposed site phases; the ability to expand into other states; expectations of operational efficiencies; total processing capacity; the ability to anticipate the future needs of customers; plans for future products and enhancements of existing products; future growth strategy and growth rate; future intellectual property; regulatory approvals and other matters; and anticipated trends and challenges in the markets in which the Company may operate.

Such forward-looking statements are subject to known and unknown risks, uncertainties and other important factors that may cause the actual results to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: business, economic and capital market conditions; the ability to manage the Company’s operating expenses, which may adversely affect the Company’s financial condition; the Company’s ability to remain competitive; regulatory uncertainties;

market conditions and the demand and pricing for our products; exchange rate fluctuations; security threats; the Company’s relationships with its customers, distributors and business partners; the Company’s ability to attract, retain and motivate qualified personnel; industry competition; the impact of technology changes on the Company’s products and industry; the Company’s ability to successfully maintain and enforce its intellectual property rights and defend third-party claims of infringement of their intellectual property rights; the impact of litigation that could materially and adversely affect our business; the Company’s ability to manage its working capital; and the Company’s dependence on key personnel. The Company is not a positive cash flow company and it may not actually achieve its plans, projections, or expectations (the Company has a history of losses).

Except as required by law, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither the Company nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this news release.

Amendments to Celista Joint Venture Agreement Facilitate $6.3 Million in Capital to Conclude Construction of 10,000 Square Foot Celista Property

Kelowna, British Columbia–(Newsfile Corp. – November 12, 2019) – Citation Growth Corp. (CSE: CGRO) (OTCQX: CGOTF) (“Citation” or the “Company“), a licensed cannabis cultivator and producer, announces that it has entered into an amended agreement (the “Amended Agreement”) with 1186626 B.C. Ltd. (“1186626 “) in connection with its joint venture agreement (the “JV Agreement”) on the Company’s Celista property located in British Columbia (the “Celista Project”).

Management has been resolute in their discovery of non-dilutive financing opportunities, in their commitment to maintain the integrity of the capital stricture. “We are very pleased with how this partnership has evolved. We have a big vision for this project, and are ready to move forward, full speed ahead, having the funding set in place.” Stated, Rahim Mohamed, President. The Company is currently in the process of constructing the first two of ten buildings, totaling 100,000 square feet of cultivation and processing space at this project.

Pursuant to the JV Agreement, 1186626 was to provide a capital contribution in the aggregate amount of $10 million (the “Capital Contribution”) to be delivered to the Company in four tranches of $2.5 million for the construction of ten 10,000 square foot cannabis production facilities. From the date of the agreement until the third year that all ten facilities are fully operational and in full production, project distributable cash flow (the “Project Distributable Cash”) will be allocated as to 50% each to the Company and 1186626, and 100% to the Company thereafter.

Under the terms of the Amended Agreement, the Capital Contribution will be $6,350,000 (the “Amended Contribution) to finance the completion of the Company’s 10,000 square foot facility, and the Project Distributable Cash has been amended as to 80% to 1186626 and 20% to the Company until the first year anniversary that 1186626’s Amended Contribution has been fully repaid, and 100% to the Company thereafter.

All other terms and conditions of the JV Agreement remain the same.

In consideration of the Amended Agreement, the Company agreed to terminate its joint venture agreement with 1186626 with respect to the Chase property located in British Columbia. Additionally, further to the Company’s press release dated April 22, 2019, the Company agreed to assign all of its right, title, interest in and to the Bud For You Inc. to 1186626.

About Citation Growth Corp.

Citation Growth Corp. is a publicly traded company that has been investing in the medical and recreational cannabis space since 2014. Citation has rapidly expanded its operating portfolio to

include cultivation, production, and dispensary locations in key North American state-legal jurisdictions and is seeking expansion opportunities worldwide.

For Further Information:

Rahim Mohamed, President

RM@citationgrowth.com

1-877-438-5448 Extension 718

Paul Searle, Corporate Communications 1-877-438-5448 Extension 714 psearle@citationgrowth.com

www.citationgrowth.com

Stock Exchanges:

Citation trades in Canada, under the ticker symbol “CGRO” on the CSE, and in the U.S., under the ticker symbol “CGOTF” on the OTCQX Best Market (the “OTCQX”). The Company also trades on other recognized platforms in Europe including Frankfurt, Stuttgart, Tradegate, L & S, Quotnx, Dusseldorf, Munich, and Berlin.

Neither the CSE nor its Regulation Services Provider, nor the OTCQX has approved nor disapproved the contents of this press release. Neither the CSE, nor the OTCQX accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements:

This news release contains forward-looking statements that relate to our current expectations and views of future events. These statements relate to future events or future performance. Statements which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, outlook, expectations or intentions regarding the future including words or phrases such as “anticipate”, “become”, “objective”, “may”, “will”, “might”, “should”, “could”, “can”, “intend”, “expect”, “believe”, “estimate”, “predict”, “potential”, “plan”, “is designed to”, “project”, “continue”, or similar expressions suggest future outcomes or the negative thereof or similar variations. Forward-looking statements may also include, among other things, statements about the Company’s: future business strategy; operations and growth strategies; expectations of obtaining licenses and permits; expectations regarding expenses, sales and operations; future customer concentration; anticipated cash needs and estimates regarding capital requirements and the need for additional financing; ability to raise future financing; completion of all proposed site phases; the ability to expand into other states; expectations of operational efficiencies; total processing capacity; the ability to anticipate the future needs of customers; plans for future products and enhancements of existing products; future growth strategy and growth rate; future intellectual property; regulatory approvals and other matters; and anticipated trends and challenges in the markets in which the Company may operate.

Such forward-looking statements are subject to known and unknown risks, uncertainties and other important factors that may cause the actual results to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: business, economic and capital market conditions; the ability to manage the Company’s operating expenses, which may adversely affect the Company’s financial condition; the Company’s ability to remain competitive; regulatory uncertainties;

market conditions and the demand and pricing for our products; exchange rate fluctuations; security threats; the Company’s relationships with its customers, distributors and business partners; the Company’s ability to attract, retain and motivate qualified personnel; industry competition; the impact of technology changes on the Company’s products and industry; the Company’s ability to successfully maintain and enforce its intellectual property rights and defend third-party claims of infringement of their intellectual property rights; the impact of litigation that could materially and adversely affect our business; the Company’s ability to manage its working capital; and the Company’s dependence on key personnel. The Company is not a positive cash flow company and it may not actually achieve its plans, projections, or expectations (the Company has a history of losses).

Except as required by law, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither the Company nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this news release.

Emerging Nevada marketplace is this company’s initial focus following acquisition

Nevada’s cannabis market is worth USD$580 million in its first year of legal recreational use

Following its American Cannabis Cultivators (ACC) acquisition, Citation Growth Corp. is focused on organic production, genetics and distribution in Nevada

Organic production is a crucial differentiator for Citation Growth Corp., Nevada’s only triple-certified organic cannabis producer

Nevada’s cannabis market hit USD$639 million in sales in its most recent fiscal year, which is a 20 per cent jump from USD$530 million over the same period last year. The key difference is that 2019 was the state’s first full year where recreational cannabis use was legal. So, with more than 60 million tourists visiting Nevada each year, the potential for growth is momentous.

Over the last few years, Canada and several U.S. states have legalized recreational cannabis, however, the resulting rush of companies into the nascent marketplace has generated volatile results for early investors. This has prompted some analysts to recommend looking at the industry through a new lens and consider cannabis as a long-term investment with the potential to pay off over time as companies mature, and especially as cannabis use eats into alcohol and pharmaceutical sales.

Entering the cannabis market as a triple-threat contender 

With a lucrative market and endless opportunities, Canada’s Citation Growth Corp. (CSE: CGRO, OTCQX: CGOTF) hopes to stake an early but lasting claim with an integrated, multi-state seed-to-sale operation focused on cultivating quality, certified-organic product lines.

Producing triple-certified organic cannabis makes us the only facility in the country with this designation. It allows the consumer to feel comfortable with the product they are purchasing while being confident it sets high standards for quality and safety.”

Howard Misle, CEO, Citation Growth Corp.

The company completed the acquisition of American Cannabis Cultivators in August this year, bringing it a rich collection of genetic strains and new CEO, Howard Misle’s 16-year track cultivation record. Plus, Citation also inherited a substantial foothold in Nevada’s tremendous marketplace with licenses for up to 569,600-sq.-ft. of cultivation, making the company one of the largest licensed footprint holders in a state that has a current moratorium on licenses.

Establishing strong operations in a state popular with year-round tourists will set the company up for financial stability and will thus allow growth into other marketplaces where it already holds cultivation and distribution licenses. Citation’s president, Rahim Mohamed, notes, “Last year, approximately 62 million tourists entered the state of Nevada, predominantly in the city of Las Vegas. That is nearly double the population of Canada moving through one city in one year.”

Mohamed explains that the company has an established cultivation facility in Pahrump, about 50 minutes outside of Vegas, and has just completed construction of a production facility closer to the city located in North Las Vegas in Oct. 2019. Facilities in North Las Vegas each have three organic certifications: EnvirOrganic Farm Certification, Certified Kind and Clean Green Certified. These organic certifications are also underway in Pahrump.

Setting a new standard for organic production 

Citation’s certifications make the company the only triple-certified organic cannabis producer in the state, a key differentiator with health-conscious cannabis consumers.

“Producing triple-certified organic cannabis makes us the only facility in the country with this designation,” adds CEO, Howard Misle. “It allows the consumer to feel comfortable with the product they are purchasing while being confident it sets high standards for quality and safety.”

The promise to produce premium cannabis for consumers comes at an important time when other cannabis producers have faced backlash over tainted products hitting the market without being detected. Canopy Growth Corp and OrganiGram Holdings have both faced the consequences of selling tainted products to consumers back in 2017.

Despite the negativity hitting the press around cannabis, Citation is setting a new standard for its quality control measures in every jurisdiction that it operates in. The company cultivates specific genetics using state-of-the-art processes and grows its product in small batches in living soil. Growing cannabis in smaller batches in controlled environments allows Citation to maintain quality and minimize losses caused by any issues, which has dogged some producers in this new industry. Additionally, the company cures its end product instead of adhering to the more typical dehydration method.

Citation’s cannabis products will hit the shelves quickly after cultivation, satisfying increasing consumer demand with a fresh product. The company also has six brands to offer consumers: Blunt Box, Gardens of WeEden, Superior, Fiore triple-certified, Diamante Labs and PureCloud 9.

Citation cultivates every three days in Pahrump and every seven days in North Las Vegas, and all of its cannabis is pre-sold, meaning the company is not storing any of its cultivated cannabis for long periods of time, allowing for maximum freshness

“Our goal is not to be a mass producer of cannabis, but rather a supplier of quality cannabis,” Misle explains. “We really want to be known for our premium quality. There are going to be growing pains in any new industry. However, we’re learning from the mistakes of others, which has taught us to do some things differently.”

Growth, licenses and hope for CBD 

Citation has cultivation facilities in California, Washington State and British Columbia, Canada at various stages of development, all with the same goal of becoming certified organic producers. Citation also has fully operational extraction and production facilities in North Las Vegas at their Apex campus.

The company is developing two cultivation sites in British Columbia — one in Celista in the North Shuswap area with the potential for ten 10,000-sq.-ft. buildings, of which two 10,000-sq.-ft. buildings are near completion and the other, a 100-acre joint venture in Chase already approved for 486,000-sq.-ft. of cultivation.

In Washington State, the company has 13.8 acres of cannabis-zoned property, and in California’s Desert Hot Springs, Citation has two cultivation and production centers in the works. Both facilities in Washington and California will be further developed once the sites in British Columbia have been completed.

While cultivating its organic strains is the immediate priority, moving from a wholesale provider to a larger retail footprint is next.

“For us to be really profitable we have to be a seed-to-sale integrated company, so having a dispensary is on the top of our priority list,” Mohamed explains.

The company has seven retail licenses in Nevada that it could develop into dispensaries in the future and is looking at potentially purchasing some existing dispensaries as well. Selling directly into the retail market would potentially double their current $1-million monthly revenues in the state, with many organic products selling for about USD$3,000-$3,200/pound wholesale and climbing up to USD$8,300 retail.

In the future, Citation plans on expanding sales into additional marketplaces by white labelling their products and bringing other producers’ products into their stores. Interestingly, they are also tracking the emerging marketplace for CBD oil, a cannabis extract that has shown potential for numerous things. 

“We eventually hope to get into CBD,” Misle says. “It is on our radar and we are working on that as we speak.”

An extremely talented and knowledgeable team leads Citation. Misle, alone, has been involved in the cannabis sector since 2003 and played an integral role in the Nevada cultivation scene since legalization.

The company also boasts president and director, Rahim Mohamed, who’s 23-year international career in the private and public sector has propped him up to be instrumental in closing multiple mergers and acquisitions; and positioning Citation as one of the largest licensed footprint holders in the state of Nevada.

For investors learning about the company — based on its projections, Citation expects its total revenues in Nevada to hit over $350-million annually, upon completion of the entire build-out in both Pahrump and North Las Vegas. The company is on the rise, and it’s strategically making its way through the evolving cannabis sector.

With Citation’s brand portfolio, its flagship facilities in Nevada already generating revenue, paired with the company’s organic methodology and more, it is evident that Citation’s trajectory to become a leading powerhouse is on the horizon.

To learn more about Citation Growth Corp, see their website here.

For further information, contact Citation at 1-877-438-5448 — Extension 718.

This story was provided by Market One Media Group for commercial purposes.

Article Link

Kelowna, British Columbia–(Newsfile Corp. – November 6, 2019) – Citation Growth Corp. (CSE: CGRO) (OTCQX: CGOTF) (“Citation” or the “Company“), a licensed cannabis cultivator and producer, is pleased to announce that Mr. Alnoor Nathoo has joined the Company’s board of directors. Mr. Nathoo brings with him a wealth of public and private company experience. Mr. Nathoo is principal of a privately held hotel development company which over the past two decades has developed and sold over 10 hotels across Canada. Prior to that, Mr. Nathoo was an investment advisor with Global Securities Corporation. Mr. Nathoo currently sits on the board of Softlab9 Software Solutions Inc.

To make room on the board for Mr. Nathoo, Mr. Raman Gill has resigned from the board of directors. The Company would like to thank Mr. Gill for his services and contributions to the Company.

Rahim Mohamed, Director & President of Citation commented, “We are very pleased to welcome Mr. Nathoo to the board of Citation. Mr. Nathoo was instrumental in funding ACC Enterprises privately and continued to support Citation since the closing of the merger with ACC. I look forward to working with Mr. Nathoo as we continue to focus on the high growth Nevada cannabis market through our cultivation and extraction assets in Pahrump and Las Vegas.” 

About Citation Growth Corp.

Citation Growth Corp. is a publicly traded company that has been investing in the medical and recreational cannabis space since 2014. Citation has rapidly expanded its operating portfolio to include cultivation, production, and dispensary locations in key North American state-legal jurisdictions and is seeking expansion opportunities worldwide.

For Further Information:

Rahim Mohamed, President
RM@citationgrowth.com
1-877-438-5448 Extension 718

Paul Searle, Corporate Communications
1-877-438-5448 Extension 714
psearle@citationgrowth.com

www.citationgrowth.com

Stock Exchanges:

Citation trades in Canada, under the ticker symbol “CGRO” on the CSE, and in the U.S., under the ticker symbol “CGOTF” on the OTCQX Best Market (the “OTCQX”). The Company also trades on other recognized platforms in Europe including Frankfurt, Stuttgart, Tradegate, L & S, Quotnx, Dusseldorf, Munich, and Berlin.

Neither the CSE nor its Regulation Services Provider, nor the OTCQX has approved nor disapproved the contents of this press release. Neither the CSE, nor the OTCQX accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements:

This news release contains forward-looking statements that relate to our current expectations and views of future events. These statements relate to future events or future performance. Statements which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, outlook, expectations or intentions regarding the future including words or phrases such as “anticipate”, “become”, “objective”, “may”, “will”, “might”, “should”, “could”, “can”, “intend”, “expect”, “believe”, “estimate”, “predict”, “potential”, “plan”, “is designed to”, “project”, “continue”, or similar expressions suggest future outcomes or the negative thereof or similar variations. Forward-looking statements may also include, among other things, statements about the Company’s: future business strategy; operations and growth strategies; expectations of obtaining licenses and permits; expectations regarding expenses, sales and operations; future customer concentration; anticipated cash needs and estimates regarding capital requirements and the need for additional financing; ability to raise future financing; completion of all proposed site phases; the ability to expand into other states; expectations of operational efficiencies; total processing capacity; the ability to anticipate the future needs of customers; plans for future products and enhancements of existing products; future growth strategy and growth rate; future intellectual property; regulatory approvals and other matters; and anticipated trends and challenges in the markets in which the Company may operate.

Such forward-looking statements are subject to known and unknown risks, uncertainties and other important factors that may cause the actual results to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: business, economic and capital market conditions; the ability to manage the Company’s operating expenses, which may adversely affect the Company’s financial condition; the Company’s ability to remain competitive; regulatory uncertainties; market conditions and the demand and pricing for our products; exchange rate fluctuations; security threats; the Company’s relationships with its customers, distributors and business partners; the Company’s ability to attract, retain and motivate qualified personnel; industry competition; the impact of technology changes on the Company’s products and industry; the Company’s ability to successfully maintain and enforce its intellectual property rights and defend third-party claims of infringement of their intellectual property rights; the impact of litigation that could materially and adversely affect our business; the Company’s ability to manage its working capital; and the Company’s dependence on key personnel. The Company is not a positive cash flow company and it may not actually achieve its plans, projections, or expectations (the Company has a history of losses).

Except as required by law, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither the Company nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this news release.

Kelowna, British Columbia–(Newsfile Corp. – October 30, 2019) – Citation Growth Corp. (CSE: CGRO) (OTCQX: CGOTF) (“Citation” or the “Company“), a licensed cannabis cultivator and producer, announces that it has completed a non-brokered private placement (the “Private Placement”) of 3,615,000 units at $0.30 per unit for gross proceeds of $1,084,500. Each unit consists of one common share and one-half of one share purchase warrant. Each whole warrant is exercisable into one common share at an exercise price of $0.60 per share for a period of two years expiring October 30, 2021. The warrants are subject to an accelerated expiry date if the trading price of the Company’s common shares closes at or above $1.00 per share for a period of ten consecutive trading days.

The proceeds from the Private Placement will be used for general working capital purposes.

All securities issued under the Private Placement are subject to a four month hold period expiring March 1, 2020.

Participation of insiders of the Company in the Private Placement constitutes a related party transaction as defined under Multilateral Instrument 61-101 (Protection of Minority Security Holders in Special Transactions). Since the Company’s shares trade only on the CSE, the issuance of securities is exempt from the formal valuation requirements of Section 5.4 of MI 61-101 pursuant to Subsection 5.5(b) of MI 61-101 and exempt from the minority approval requirements of Section 5.6 of MI 61-101.

About Citation Growth Corp.

Citation Growth Corp. is a publicly traded company that has been investing in the medical and recreational cannabis space since 2014. Citation has rapidly expanded its operating portfolio to include cultivation, production, and dispensary locations in key North American state-legal jurisdictions and is seeking expansion opportunities worldwide.

For Further Information:

Rahim Mohamed, President 1-877-438-5448 Extension 718 RM@citationgrowth.com

Paul Searle, Corporate Communications 1-877-438-5448 Extension 714 psearle@citationgrowth.com

www.citationgrowth.com

Stock Exchanges:

Citation trades in Canada, under the ticker symbol “CGRO” on the CSE, and in the U.S., under the ticker symbol “CGOTF” on the OTCQX Best Market (the “OTCQX”). The Company also trades on other

recognized platforms in Europe including Frankfurt, Stuttgart, Tradegate, L & S, Quotnx, Dusseldorf, Munich, and Berlin.

Neither the CSE nor its Regulation Services Provider, nor the OTCQX has approved nor disapproved the contents of this press release. Neither the CSE, nor the OTCQX accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements:

This news release contains forward-looking statements that relate to our current expectations and views of future events. These statements relate to future events or future performance. Statements which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, outlook, expectations or intentions regarding the future including words or phrases such as “anticipate”, “become”, “objective”, “may”, “will”, “might”, “should”, “could”, “can”, “intend”, “expect”, “believe”, “estimate”, “predict”, “potential”, “plan”, “is designed to”, “project”, “continue”, or similar expressions suggest future outcomes or the negative thereof or similar variations. Forward-looking statements may also include, among other things, statements about the Company’s: future business strategy; operations and growth strategies; expectations of obtaining licenses and permits; expectations regarding expenses, sales and operations; future customer concentration; anticipated cash needs and estimates regarding capital requirements and the need for additional financing; ability to raise future financing; completion of all proposed site phases; the ability to expand into other states; expectations of operational efficiencies; total processing capacity; the ability to anticipate the future needs of customers; plans for future products and enhancements of existing products; future growth strategy and growth rate; future intellectual property; regulatory approvals and other matters; and anticipated trends and challenges in the markets in which the Company may operate.

Such forward-looking statements are subject to known and unknown risks, uncertainties and other important factors that may cause the actual results to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: business, economic and capital market conditions; the ability to manage the Company’s operating expenses, which may adversely affect the Company’s financial condition; the Company’s ability to remain competitive; regulatory uncertainties; market conditions and the demand and pricing for our products; exchange rate fluctuations; security threats; the Company’s relationships with its customers, distributors and business partners; the Company’s ability to attract, retain and motivate qualified personnel; industry competition; the impact of technology changes on the Company’s products and industry; the Company’s ability to successfully maintain and enforce its intellectual property rights and defend third-party claims of infringement of their intellectual property rights; the impact of litigation that could materially and adversely affect our business; the Company’s ability to manage its working capital; and the Company’s dependence on key personnel. The Company is not a positive cash flow company and it may not actually achieve its plans, projections, or expectations (the Company has a history of losses).

Except as required by law, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither the Company nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this news release.

Not an Offer or Solicitation:

This press release is not an offer of the Company’s securities for sale in the U.S. The securities may not be offered or sold in the U.S. absent registration or an available exemption from the registration requirements

of the U.S. Securities Act and applicable U.S. state securities laws. The Company will not make any public offering of its securities in the U.S. The Company’s securities have not been and will not be registered under the U.S. Securities Act.

THIS PRESS RELEASE IS NOT FOR DISTRIBUTION OR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW